NCT00457613
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
- Locations
-
- Radboud University Medical Centre Nijmegen, Gelderland, Netherlands
Clinical trial condition
Explore clinical trials studying Shock. Study availability and eligibility vary by location and protocol.
NCT00457613
NCT00122707
NCT07658001
NCT06713668
NCT05697770
NCT07248761
NCT05613647
NCT06573541